Has Kaiwal Patel, MD received payments from drug or device companies?

Yes. Drug and device makers reported $6,684 in general payments to Kaiwal Patel, MD across 57 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Kaiwal Patel, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Kaiwal Patel, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Kaiwal Patel, MD

Pain Medicine · Lakeland, FLNPI 1295391209

Payments from drug & device makers

$6,684in general payments, 2019–2025

Across 57 payments — averaging $117.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Boston Scientific$2K
Nevro Corp.$2K
Medtronic$1K
Saluda Medical Americas, Inc.$457
Globus Medical$190

What the payments were for

Travel & lodging$3,14247%
Food & beverage$2,40736%
Education$1,13517%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Boston Scientific	23	$2,370
Nevro Corp.	11	$2,279
Medtronic	18	$1,388
Saluda Medical Americas, Inc.	3	$457
Globus Medical	2	$190

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,684 in reported general payments places this provider in the 70th percentile of 596 pain medicine providers in Florida.

See all pain medicine providers in Florida →

Medicare billing

Part B allowed, 2024

$45,285

Medicare patients

Services billed

725

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Oxycodone Hcl	28	$584
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	24	$514
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	17	$476
Gabapentin	31	$398
Pregabalin	13	$393
Tizanidine Hcl	24	$311
Morphine Sulfate ErMorphine Sulfate	11	$201
Nortriptyline Hcl	19	$191
Duloxetine Hcl	14	$125
Meloxicam	19	$48

Paid to pharmacies, not to this prescriber.

Other pain medicine in Lakeland

Navdeep JassalLakeland$168K
Benito TorresLakeland$29K
Anand PatelOrmond Beach$20.4M
Julio PaezClermont$2.3M
Joseph PergolizziNaples$2.1M
Abel MurilloMiami$1.6M
George MonluxPalm Coast$1.3M
Ferdinand FormosoJacksonville$1M
Cesar LassalleOrlando$1M
Robert GuirguisTampa$895K

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →